
Consequences of Switching 5α-Reductase Inhibitors on Prostate Specific Antigen Velocity
Keywords: هیپرپلازی خوش خیم پروستات; prostate; prostate-specific antigen; finasteride; dutasteride; drugs; generic; 5AR; 5α-reductase; 5ARI; 5AR inhibitor; BPH; benign prostatic hyperplasia; CaP; prostate cancer; DHT; dihydrotestosterone; EDW; Enterprise Data Warehouse; LUTS; lower urinary